Tianda Pharmaceuticals Ltd. held its annual general meeting on 13 June 2025. The meeting included several proposals, all of which were approved. The proposals included receiving and considering the audited consolidated financial statements and reports for the year ended 31 December 2024, re-electing Mr. LUI Man Sang as an Executive Director, re-electing Mr. LAM Yat Fai as an Independent Non-executive Director, and re-electing Dr. Xian Yanfang as an Independent Non-executive Director.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianda Pharmaceuticals Ltd. published the original content used to generate this news brief on June 13, 2025, and is solely responsible for the information contained therein.